Log in to save to my catalogue

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03662789v1

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

About this item

Full title

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Publisher

US: Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2022-05, Vol.107 (5), p.e2056-e2064

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Context
Despite the growing evidence of the clinical value of somatostatin receptor (SSTR) positron emission tomography (PET) in the evaluation of neuroendocrine tumors (NETs), its role remains to be clarified at different time points in the journey of patients with multiple endocrine neoplasia type 1 (MEN1). The rarity of the diseas...

Alternative Titles

Full title

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03662789v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03662789v1

Other Identifiers

ISSN

0021-972X

E-ISSN

1945-7197

DOI

10.1210/clinem/dgab891

How to access this item